Biosimilar MAbs Starting to Line up for Approval
By Sharon Kingman
Wednesday, February 20, 2013
LONDON 2013 will be a watershed year for biosimilars biological therapies designed to be similar to existing biological therapeutic agents delegates attending the Second Biosimilars Congregation in London heard Tuesday.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.